Trey has served as Osteal Therapeutics'® Vice President of Regulatory Affairs and Quality Assurance since March 2022. He brings over 20 years of experience in biopharmaceutical and medical technology product development, product approval, regulatory affairs, and quality management. Trey holds a regulatory affairs certification (RAC) in U.S. regulatory affairs from the Regulatory Affairs Professional Society. Previously, Trey was Vice President and General Manager of Cardinal Health Regulatory Sciences, VP of Regulatory Affairs and CMC at FAST BioMedical and group leader/program manager at MRIGlobal. In addition, Trey has been a Professor of Clinical and Translational Science at Texas Tech University Health Sciences Center and has held multiple board appointments with biopharmaceutical and medical technology companies. 

 

Trey received a PhD and MA in Organic Chemistry from Washington University in St. Louis and a BS in Chemistry from Pittsburg State University.